Plasmacytoid Dendritic Cells in the Tumor Microenvironment: Immune Targets for Glioma Therapeutics
Marianela Candolfi(Cedars-Sinai Medical Center), María G. Castro(University of Michigan)
Cited by 62
Related Papers
HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
|PLoS Medicine|2009|366
Combined Immunostimulation and Conditional Cytotoxic Gene Therapy Provide Long-term Survival in a Large Glioma Model
|Cancer Research|2005|127
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy
|Science Advances|2021|90
Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy
|Cell Death and Disease|2018|61